🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
The standard chemotherapy for Hodgkin lymphoma is called ABVD which is a co...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-04
Trial ID
NCT01578967
Treatments Being Tested
For participants with CD30 positive Mature T-cell lymphomas who have receiv...
Status
Withdrawn
Location
The University of Kansas Cancer Center, Westwood Campus
Start Date
2020-05-29
Trial ID
NCT04334174
Treatments Being Tested
Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/...
Status
Recruiting
Location
New York Medical College
Start Date
2025-08-07
Trial ID
NCT07013565
Treatments Being Tested
To evaluate the efficacy and safety of chidamide combined with brentuximab ...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-11-01
Trial ID
NCT07074457
This is a multicenter, observational real world study with prospective foll...
Status
Unknown
Location
Hospital Nacional Posadas
Start Date
2021-06-01
Trial ID
NCT04776265
Treatments Being Tested
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
The purpose of this study is to compare the outcomes across the 4 different...
Status
Completed
Location
City of Hope
Start Date
2013-05
Trial ID
NCT01868451
The main objective of this trial is to assess whether treatment adaptation ...
Status
Active Not Recruiting
Location
ZNA Stuivenberg
Start Date
2019-08-01
Trial ID
NCT03517137
Patients are in 2 cohorts: Cohort 1: dexamethasone, methotrexate, ifosfami...
Status
Recruiting
Location
University of Alabama
Start Date
2019-03-01
Trial ID
NCT03719105